Replimune Group REPL Business Segments — Other Income (Expense)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Replimune Group's business segments — other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Replimune Group's business segments — other income (expense)?
- Replimune Group (REPL) reported business segments — other income (expense) of $627K in Q4 2025.
- How has Replimune Group's business segments — other income (expense) changed year-over-year?
- Replimune Group's business segments — other income (expense) increased by 146.9% year-over-year, from $254K to $627K.
- What does business segments — other income (expense) mean?
- Includes non-operating financial items such as interest income from cash balances, interest expense on debt, and foreign currency exchange gains or losses. This metric reflects the impact of the company's treasury management and capital structure on the bottom line, independent of core clinical operations.